Endeavor Lab™
Let’s Do This
PTS-ID™ is the first & only evidence-based, objective risk assessment tool for PTSD. A genomic assay performed on a simple blood sample, PTS-ID™ reports on gene expression levels for the three PTSD biomarkers, FKBP5, STAT5B, & NFIA, whose link to PTSD risk has been validated in hundreds of cases & controls.
Developed from decades of research & analysis on blood samples from 9/11 first responders, sexual assault survivors, & Holocaust survivors & their descendants, PTS-ID™ helps clinicians confidently & quickly assess a person’s risk of experiencing the stress dysregulation associated with PTSD.
PTS-ID™ results are combined with behavioral risk survey data for a comprehensive behavioral profile. Results can also be integrated with multi-omic data & analyzed with the Polaris TruNorth™ Platform to give clinicians a wholepicture view of a person’s health, enabling even more targeted & effective treatment.
We’re here — are you ready?
Lab Services
Next Generation Sequencing & Genomic Testing
Our primary expertise is genomic sequencing, including next-generation sequencing based on Illumina platforms. We offer whole genome, whole exome, RNAseq, & DNA methylation sequencing from a variety of specimen types, including blood, saliva, & tissue blocks.
- Translational research in the clinical setting
- High-complexity testing for a variety of conditions
- qPCR- & NGS-based genetic tests
CLIA / CAP Clinical Genetic Testing
We conduct CLIA- / CAP-certified clinical genetic testing for a range of conditions, including mental & behavioral health conditions (such as PTSD), musculoskeletal disorders, cancer, & respiratory virus testing.
- Neuropsychiatric genomic analysis (including PTS-ID™ & TruNorth™)
- Whole genome (30X) & whole exome sequencing
- DNA methylation analysis
- RNA seq gene expression analysis
- Quantitative reverse transcriptase PCR (qPCR) assays
Bioinformatic Data Analysis
Equip your team with our technology & expertise in complex analysis of genomic sequencing data. Our platform enables rapid & accurate analysis of multi-omic sequence data.
- Secure cloud-based bioinformatic data analysis platform
- Machine learning (ML) & artificial intelligence (AI) algorithms
- Proprietary neuropsychiatric panel